Urgent.News

What's breaking now, across thousands of outlets.

Science

GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.

GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

More from Monday 19 October →